Parexel's Ethnobridging Expert Discusses Its Importance as a Development Strategy

Parexel’s Ethnobridging Expert Discusses Its Importance as a Development Strategy

Stan Jhee, PharmD, Senior Director of Research, Early Phase at Parexel, defines the importance of ethnobridging in clinical trials, and how it works as a drug development strategy for pharmaceutical companies.